Company news

Cytek Biosciences, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions

March 6, 2024

Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook

February 27, 2024

Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

February 6, 2024

Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries

January 16, 2024

Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results

January 7, 2024

Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry

December 20, 2023

Cytek® Aurora™ CS System Wins BioTech Breakthrough Award for ‘Cell Sorting Product of the Year’

November 7, 2023

Cytek Biosciences Reports Third Quarter 2023 Financial Results

November 6, 2023

Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023

October 18, 2023

Cytek® Biosciences Achieves ISO 13485 Certification at Headquarters

September 26, 2023

Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry

September 13, 2023

Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services

August 27, 2023

Cytek Biosciences Reports Second Quarter 2023 Financial Results

August 7, 2023

Cytek Biosciences to Report Second Quarter 2023 Financial Results on August 8, 2023

July 19, 2023

Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward

May 15, 2023

Cytek Biosciences Reports First Quarter 2023 Financial Results

May 8, 2023

Cytek Biosciences Set to Join S&P SmallCap 600

April 24, 2023

Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023

April 19, 2023

Cytek® Biosciences Introduces New 20-Color AML Panel

March 6, 2023

Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results

February 27, 2023

Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin

February 12, 2023

Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023

February 6, 2023

Cytek® Biosciences Introduces Cytek Cloud

November 14, 2022

Cytek Biosciences Reports Third Quarter 2022 Financial Results

November 8, 2022

Cytek® Biosciences Names Chris Williams Chief Operating Officer

October 30, 2022

Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022

October 25, 2022

Cytek Biosciences Reports Second Quarter 2022 Financial Results

August 9, 2022

Cytek Biosciences to Report Second Quarter 2022 Financial Results on August 10, 2022

July 19, 2022

Cytek® Biosciences Receives CE Marking for Series of cFluor® Reagents, TBNK Kit

May 23, 2022

Cytek Biosciences Reports First Quarter 2022 Financial Results

May 10, 2022

Cytek Biosciences to Report First Quarter Financial Results on May 11, 2022

April 27, 2022

Cytek Biosciences Appoints Todd Garland Chief Commercial Officer

April 27, 2022

Cytek Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results

February 22, 2022

Cytek® Biosciences Expands Fremont Headquarters, Tripling Its Manufacturing Capacity

January 4, 2022

Cytek® Biosciences Marks Milestone Achievement with Shipment of 1000th Cell Analysis System

November 16, 2021

Cytek Biosciences Reports Third Quarter 2021 Financial Results

November 7, 2021

Cytek Biosciences Acquires Tonbo Biosciences’ Cell Analysis Business

November 2, 2021

Cytek Biosciences to Report Third Quarter Financial Results on November 8, 2021

October 25, 2021

Cytek® Biosciences Introduces New 25-Color Immunoprofiling Assay

October 6, 2021

Cytek Biosciences Reports Second Quarter 2021 Financial Results

September 1, 2021

Cytek Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

August 1, 2021

Cytek Biosciences Announces Closing of Its Initial Public Offering

July 26, 2021

← Newer news releases

Calls

The 5 newest of 21 calls. Every call is listed under its year.

Decks

The 5 newest of 11 decks. Every deck is listed under its year.